For the quarter ending 2025-09-30, AARD has $133,229K in assets. $10,852K in debts. $39,285K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 39,285 | 25,998 | ||
| Short-term investments | 87,065 | 115,822 | ||
| Prepaid expenses and other current assets | 2,857 | 2,948 | ||
| Total current assets | 129,207 | 144,768 | ||
| Operating lease right-of-use asset | 439 | 522 | ||
| Other assets | 3,583 | 2,185 | ||
| Total assets | 133,229 | 147,475 | ||
| Accounts payable | 4,444 | 5,056 | ||
| Operating lease liability, current portion | 429 | 417 | ||
| Accrued liabilities | 5,863 | 4,837 | ||
| Total current liabilities | 10,736 | 10,310 | ||
| Operating lease liability, net of current portion | 116 | 228 | ||
| Other long-term liabilities | 0 | 12 | ||
| Total liabilities | 10,852 | 10,550 | ||
| Additional paid-in capital | 220,615 | 218,932 | ||
| Accumulated other comprehensive income | 82 | -3 | ||
| Accumulated deficit | -98,320 | -82,004 | ||
| Total stockholders' equity (deficit) | 122,377 | 136,925 | ||
| Total liabilities, convertible preferred stock and stockholders' equity (deficit) | 133,229 | 147,475 | ||
Aardvark Therapeutics, Inc. (AARD)
Aardvark Therapeutics, Inc. (AARD)